Investors & Media

Sangamo is pioneering the future of genomic medicine

Sangamo Therapeutics is a genomic medicine company dedicated to translating groundbreaking science into medicines that transform the lives of patients and families afflicted with serious neurological disease. Sangamo uses its deep scientific expertise and proprietary zinc finger technology to create genomic cures for patients suffering from diseases for which today’s medicine can only offer symptom management at best.

Stock Quote

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Latest News Releases

Filing date Form Description Filing Group View
SC 13G/A

An amendment to the SC 13G filing

Other
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML

Upcoming Events
  • More events are coming soon.
Past Events

Contacts